Medications

US makes new Alzheimer's drug more widely accessible

The US drug regulator gave full approval to a new Alzheimer's medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.

Neuroscience

Astrocyte dysfunction found to cause cognitive decline

People with dementia have protein build-up in astrocytes that may trigger abnormal antiviral activity and memory loss, according to a preclinical study by a team of Weill Cornell Medicine investigators.

Neuroscience

Smartphone app can significantly improve memory recall

Researchers at the University of Toronto have demonstrated that a new smartphone application helps to significantly improve memory recall, which could prove beneficial for individuals in the early stages of Alzheimer's disease ...

page 4 from 24